Bayer’s weed-killer caused cancer, says US jury


A US jury on Tuesday found Bayer AG's glyphosate-based Roundup weed killer caused cancer, a blow to the company eight months after another jury issued a $289 million verdict over similar claims in a different case.

Tuesday's unanimous jury decision in San Francisco federal court, which came after five days of deliberation, was not a finding of Bayer's liability for the cancer of plaintiff Edwin Hardeman. Liability and damages will be decided by the same jury in a second trial phase beginning on Wednesday.

Bayer, which denies allegations that glyphosate or Roundup cause cancer, in a statement on Tuesday said it was disappointed with the jury's initial decision. Bayer acquired Monsanto, the longtime maker of Roundup, for $63 billion last year.

“We are confident the evidence in phase two will show that Monsanto's conduct has been appropriate and the company should not be liable for Mr. Hardeman's cancer,” the company said.

Shares in Bayer were down 9.6 per cent at 0709 GMT in early Frankfurt trade.

Glyphosate is the world's most widely used weed killer. Monsanto's Roundup was the first glyphosate-based weed killer but is no longer patent-protected and many other versions are now available. Bayer does not provide sales figures for the product......Read more

 

Source web page: The business line


Comments (0)



Please Login or Register to join groups